Morgan Stanley
-
-
-
-
-
-
-
TScan Therapeutics, Inc (TCRX) Announces Pricing of Upsized $150 Million Public Offering
-
-
-
-
-
-
-
TScan Therapeutics Announces Pricing of $140 Million Public Offering
-
-
-
-
-
-
-
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

